Viruses make obvious targets for RNAi intervention, given that they utilize specific cellular receptors and introduce foreign genes into host cells, researchers at the Wolfson Institute for Biomedical Research at University College London wrote in an article in Current Opinions in Infectious Diseases. Hepatitis C and HIV have been very aggressively pursued thus far, but a number of other viral-associated diseases, namely cancers, make promising targets for the gene silencing technology.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.